Literature DB >> 26667157

Potential Roles of Humanin on Apoptosis in the Heart.

Savitree T Charununtakorn1,2,3, Krekwit Shinlapawittayatorn1,2,3, Siriporn C Chattipakorn1,2,3,4, Nipon Chattipakorn1,2,3.   

Abstract

The process of programmed cell death, or apoptosis, is known as a key player in the development and progression of cardiovascular disease. The proposed mechanism for apoptosis is the activation of two main apoptotic signaling pathways (the extrinsic and intrinsic pathways), which lead to cell death. As the rate and amount of cardiomyocyte loss is the most important determinant of patient morbidity and mortality, novel treatment strategies targeting apoptosis are crucial. Recently, Humanin has been shown to exert protective effects against cellular apoptosis in both experimental and clinical studies. The potential cardioprotective mechanisms of Humanin have been shown to involve both the extracellular and intracellular signaling pathways. In this review, the current knowledge and the mechanisms inhibiting cellular apoptosis by Humanin during cardiac injury are comprehensively summarized. In addition, both research and clinical findings regarding the effects of Humanin on the heart and vasculature are also presented and discussed. Currently available information suggests that Humanin may exert cardioprotective benefits and could potentially be used as a novel pharmacological intervention against cellular apoptosis during myocardial injury.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Apoptosis; Heart; Humanin; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 26667157     DOI: 10.1111/1755-5922.12168

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  13 in total

1.  Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice.

Authors:  Qing Qin; Hemal Mehta; Kelvin Yen; Gerardo Navarrete; Sebastian Brandhorst; Junxiang Wan; Silvia Delrio; Xin Zhang; Lilach O Lerman; Pinchas Cohen; Amir Lerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-13       Impact factor: 4.733

2.  The circular RNA ZNF292 alleviates OGD-induced injury in H9c2 cells via targeting BNIP3.

Authors:  Qi Ren; Hu Li; Xiaowen Wang
Journal:  Cell Cycle       Date:  2019-10-13       Impact factor: 4.534

3.  Local Ancestry and Clinical Cardiovascular Events Among African Americans From the Atherosclerosis Risk in Communities Study.

Authors:  Aditi Shendre; Marguerite R Irvin; Howard Wiener; Degui Zhi; Nita A Limdi; Edgar T Overton; Sadeep Shrestha
Journal:  J Am Heart Assoc       Date:  2017-04-10       Impact factor: 5.501

4.  lncRNA-ZFAS1 induces mitochondria-mediated apoptosis by causing cytosolic Ca2+ overload in myocardial infarction mice model.

Authors:  Lei Jiao; Mengmeng Li; Yingchun Shao; Yuanyuan Zhang; Manyu Gong; Xuewen Yang; Yanying Wang; Zhongyue Tan; Lihua Sun; Lina Xuan; Qi Yu; Yanru Li; Yuqiu Gao; Heng Liu; Honglin Xu; Xiaohan Li; Yong Zhang; Ying Zhang
Journal:  Cell Death Dis       Date:  2019-12-09       Impact factor: 8.469

5.  Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.

Authors:  Jing Zhang; Lelin Huang; Xing Shi; Liu Yang; Fuzhou Hua; Jianyong Ma; Wengen Zhu; Xiao Liu; Rui Xuan; Yunfeng Shen; Jianping Liu; Xiaoyang Lai; Peng Yu
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

Review 6.  The Molecular Structure and Role of Humanin in Neural and Skeletal Diseases, and in Tissue Regeneration.

Authors:  Sipin Zhu; Xiaoyong Hu; Samuel Bennett; Jiake Xu; Yuliang Mai
Journal:  Front Cell Dev Biol       Date:  2022-03-16

Review 7.  Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.

Authors:  Zhihan Chen; Jingping Wu; Sijing Li; Caijiao Liu; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

8.  Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.

Authors:  Yanhe Lue; Chen Gao; Ronald Swerdloff; James Hoang; Rozeta Avetisyan; Yue Jia; Meng Rao; Shuxun Ren; Vince Atienza; Junyi Yu; Ye Zhang; Mengping Chen; Yang Song; Yibin Wang; Christina Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 5.125

9.  Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.

Authors:  Xiaoxue Yu; Yang Ruan; Tao Shen; Quan Qiu; Mingjing Yan; Shenghui Sun; Lin Dou; Xiuqing Huang; Que Wang; Xiyue Zhang; Yong Man; Weiqing Tang; Zening Jin; Jian Li
Journal:  Biomed Res Int       Date:  2020-03-01       Impact factor: 3.411

Review 10.  Mitochondria Related Cell Death Modalities and Disease.

Authors:  Chuwen Tian; Yifan Liu; Zhuoshu Li; Ping Zhu; Mingyi Zhao
Journal:  Front Cell Dev Biol       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.